Jun 07, 07
|
| NEW STORY |
| 10:25 ET |
Mallinckrodt Launches Magnacet(TM) Tablets
|
|
Mar 13, 07
|
| 14:29 ET |
Mallinckrodt Initiates Voluntary Imaging Product Recall
|
|
Oct 20, 00
|
| 11:16 ET |
Nellcor(R) OEM Pulse Oximetry Shipments Up 22% in First Quarter
|
|
Oct 17, 00
|
| 17:43 ET |
Two Studies Presented at Anesthesiologists Conference Conclude Mallinckrodt's Nellcor(R) n-395 Pulse Oximeter Superior During Motion and Low Perfusion
|
|
Oct 12, 00
|
| 17:12 ET |
Data Critical to Provide Mallinckrodt with Wireless Connectivity For Ventilators
|
|
| 16:38 ET |
Mallinckrodt's Respiratory Group Receives Zenith Award From American Association for Respiratory Care
|
|
Oct 11, 00
|
| 15:40 ET |
Study Concludes Nellcor(R) N-395 Pulse Oximeter Superior During Difficult Conditions
|
|
Oct 10, 00
|
| 11:37 ET |
Mallinckrodt Applauds Court Dismissal of Masimo Patent Infringement Claim
|
|
Oct 02, 00
|
| 15:06 ET |
Mallinckrodt, Invacare Enter Alliance For Invacare To Distribute Mallinckrodt's Line of Oxygen Therapy Products
|
|
Sep 28, 00
|
| 17:53 ET |
Welch Allyn Protocol and Mallinckrodt's Nellcor Oximetry Business Announce Expanded Business Relationship
|
|
Sep 19, 00
|
| 17:02 ET |
Mallinckrodt Shareholders Approve Merger with Tyco
|
|
Sep 14, 00
|
| 14:21 ET |
Two Studies Conclude Mallinckrodt's Nellcor(R) N-395 Pulse Oximeters Superior During Motion and Low Perfusion
|
|
Sep 12, 00
|
| 16:01 ET |
Mallinckrodt's Nellcor(R) Oximetry Business Achieves Record-Breaking FY2000 Sales of Stand-Alone Monitors
|
|
Sep 06, 00
|
| 10:48 ET |
Mallinckrodt's Fetal Oxygen Monitoring Technology To Be Featured at FIGO World Congress
|
|
Aug 31, 00
|
| 13:31 ET |
Design Improvements Make Mallinckrodt's Simplicity(R) Spirometer More Efficient, User-Friendly
|
|
Aug 22, 00
|
| 15:37 ET |
Mallinckrodt Directors Declare Quarterly Dividend
|
|
Aug 10, 00
|
| 09:00 ET |
Mallinckrodt Reports Fiscal Year 2000 EPS from Continuing Operations of $2.96, Up 23 Percent Over Prior Year
|
|
Aug 01, 00
|
| 19:11 ET |
Hydrocodone Bitartrate and Acetaminophen Tablets, USP (10 Mg/325 Mg) Approved For U.S. Marketing
|
|
| 12:01 ET |
Mallinckrodt and Premier Sign Agreement for ProstaSeed(TM)
|
|
| 11:44 ET |
Mallinckrodt's Nellcor Oximetry Business Announces Schedule for Critical Care Medicine Seminars
|
|
Jul 25, 00
|
| 13:51 ET |
Mallinckrodt and HSCA Sign Agreement for Nellcor(R) Monitors and Sensors
|
|
Jul 13, 00
|
| 14:21 ET |
Mallinckrodt Highlights New OxiFirst Fetal Oxygen Monitoring Technology at Congressional Healthcare Leadership Council
|
|
Jul 11, 00
|
| 10:57 ET |
Mallinckrodt's Nellcor Oximetry Dramatization Earns High Honors At U.S. International Film and Video Festival
|
|
Jul 10, 00
|
| 15:47 ET |
FDA Advisory Committee Finds Palatin Technologies' LeuTech(R) Infection Imaging Agent Safe and Effective in Unanimous Votes
|
|
Jun 12, 00
|
| 16:14 ET |
Mallinckrodt Names Reisenthel Vice President of New Healthy Mother and Baby Division
|
|
Jun 08, 00
|
| 15:27 ET |
Former Baxter Executive Joins Mallinckrodt Management
|
|
Jun 07, 00
|
| 16:22 ET |
Court Awards Mallinckrodt Litigation Costs Incurred During Defense in Patient Warming Blankets Patent Case
|
|
May 21, 00
|
| 21:00 ET |
Mallinckrodt Inc. Receives Prestigious BHQ Status From Singapore Economic Development Board
|
|
May 18, 00
|
| 13:30 ET |
Monitoring of Baby's Oxygen in the Womb Now Possible
|
|
May 16, 00
|
| 13:51 ET |
Mallinckrodt Expands ADHD Product Line Receives U.S. FDA Approval for Extended-Release Methylin(TM) Tablets
|
|
May 15, 00
|
| 16:50 ET |
Mallinckrodt Receives FDA Approval For New Fetal Monitoring System Announces Press Conference to Launch OxiFirst(TM)
|
|
May 08, 00
|
| 16:43 ET |
Molecular Biosystems, Mallinckrodt Announce Restructuring of OPTISON(R) Agreement
|
|
| 14:08 ET |
Nycomed Amersham, Mallinckrodt Agree on Ultrasound Patent Settlement, Announce Joint Development of Existing Ultrasound Products
|
|
Apr 26, 00
|
| 09:44 ET |
Mallinckrodt Directors Appoint New Board Member
|
|
Apr 18, 00
|
| 08:32 ET |
Mallinckrodt Reports Record Third-Quarter Earnings, Raises Outlook for Year
|
|
Apr 11, 00
|
| 15:09 ET |
Mallinckrodt Expands Partnership Agreement With Premier To Include Nellcor N-395 Pulse Oximeter With Oxismart(R) XL and SatSeconds(TM)
|
|
Mar 29, 00
|
| 13:44 ET |
Mallinckrodt Introduces Two New Therapeutic Systems in the United States For Treating Sleep Apnea
|
|
Mar 21, 00
|
| 14:08 ET |
AmeriNet and Mallinckrodt Form Product Integration Alliance
|
|
Mar 14, 00
|
| 13:44 ET |
Mallinckrodt Introduces New Software Option Designed to Improve Spontaneous Breathing for Patients on Ventilator Support
|
|
Feb 24, 00
|
| 12:02 ET |
Mallinckrodt's Healthcare Economics Website Brings Reimbursement Information To the Desktop
|
|
Feb 22, 00
|
| 17:01 ET |
Mallinckrodt Management to Increase Share Repurchase; Reiterates Confidence In The Year
|
|
Feb 15, 00
|
| 17:35 ET |
Heller Financial Signs Agreement to Administer Private-Label Equipment Lease Financing for Mallinckrodt Inc.
|
|
Feb 14, 00
|
| 14:28 ET |
Mallinckrodt Announces Series of Seminars on Pulse Oximetry and Critical Care Medicine
|
|
Feb 08, 00
|
| 15:36 ET |
Mallinckrodt Launches New Optistar(TM) MR Contrast Delivery System in United States Following FDA Approval
|
|
Jan 27, 00
|
| 12:57 ET |
New Fetal Oxygen Monitoring System Recommended for Approval by FDA Advisory Committee
|
|
Jan 25, 00
|
| 13:07 ET |
Mallinckrodt Reports Record Second-Quarter Earnings, Consolidation Of Respiratory Manufacturing
|
|
Jan 20, 00
|
| 12:08 ET |
Mallinckrodt Announces Results of Pulse Oximetry Study For Its Nellcor Pulse Oximetry Business
|
|
Jan 11, 00
|
| 12:28 ET |
New Fetal Monitoring System Accepted for Review by FDA
|
|
Dec 21, 99
|
| 15:04 ET |
New HELIOS (TM) Oxygen System From Mallinckrodt Removes Barriers Typically Associated With Home Oxygen Therapy
|
|
Dec 17, 99
|
| 11:45 ET |
EQT Acquires HemoCue from Mallinckrodt Inc.
|
|
Dec 15, 99
|
| 12:35 ET |
New Achieva(TM) Portable Ventilator from Mallinckrodt Suitable for Children And Adults in Subacute to Home Settings
|
|
Dec 09, 99
|
| 17:11 ET |
Mallinckrodt Receives FDA Approval For OptiMARK(TM), Contrast Agent for MRI Diagnostics
|
|
Nov 18, 99
|
| 12:30 ET |
Mallinckrodt Sues Masimo, Ivy Biomedical Systems For Infringing Three Oximetry Patents
|
|
Oct 25, 99
|
| 13:37 ET |
Mallinckrodt Improves its Oxygen Therapy Line With New Aeris(TM) 590 Oxygen Concentrator
|
|
Oct 19, 99
|
| 06:45 ET |
Mallinckrodt Reports Record First-Quarter Earnings Per Share From Continuing Operations, Increasing 23 Percent Over FY99
|
|
Oct 18, 99
|
| 15:11 ET |
Mallinckrodt to Supply Peptide to Trimeris for Novel AIDS Therapeutic
|
|
Oct 14, 99
|
| 14:56 ET |
Mallinckrodt Plans Vigorous Defense Against Patent Infringement Claim
|
|
| 12:44 ET |
Mallinckrodt and IBt Sign Letter of Intent for Distribution of Brachytherapy Seeds in Europe
|
|
Oct 11, 99
|
| 14:51 ET |
Mallinckrodt's OxiClip PC 20 Pneumatic Conserver Provides Greater Mobility And Cost Savings for Respiratory Patients
|
|
Oct 08, 99
|
| 11:12 ET |
Mallinckrodt Introduces New Dimension in Comfort for Sleep Apnea Sufferers
|
|
Sep 23, 99
|
| 12:43 ET |
Mallinckrodt Announces $11.8 Million Expansion of Hobart, N.Y., Pharmaceutical Facility
|
|
Sep 15, 99
|
| 12:06 ET |
Mallinckrodt Establishes Independent Rep Network to Work with Alternate Care Sales Team
|
|
Sep 10, 99
|
| 11:25 ET |
UroCor, Mallinckrodt Sign Agreement to Sell Prostate Cancer Radiotherapy
|
|
Sep 08, 99
|
| 13:51 ET |
Mallinckrodt, Premier Sign New Agreement for the WarmTouch(R) Convective Warming System
|
|
Aug 25, 99
|
| 17:55 ET |
Mallinckrodt Respiratory Group Introduces New, Quieter GoodKnight(R) 418G For Home Care Sleep Apnea Treatment
|
|
Aug 20, 99
|
| 12:58 ET |
Mallinckrodt Board of Directors Declares Quarterly Dividend
|
|
Aug 11, 99
|
| 06:32 ET |
Mallinckrodt Reports FY1999 Earnings Per Share from Continuing Operations, Up 36 Percent Over FY98 and Exceeds Expectations
|
|
Jul 20, 99
|
| 16:46 ET |
Mallinckrodt, Premier Sign New Extended Agreement Covering Additional Products
|
|
Jul 06, 99
|
| 16:41 ET |
Mallinckrodt Signs Agreement with SmithKline Beecham to Promote Dexedrine(R)
|
|
Jun 23, 99
|
| 13:17 ET |
Mallinckrodt Receives Accreditation for Continuing Education
|
|
Jun 22, 99
|
| 13:17 ET |
European Study Shows Oxismart Technology Reduces Nuisance Alarms
|
|
Jun 17, 99
|
| 17:15 ET |
Nellcor(R) OEM Oximetry Shipments Up 15% YTD, Mallinckrodt Announces
|
|
Jun 14, 99
|
| 16:44 ET |
Mallinckrodt Plans Vigorous Pursuit of Patient Warming Business Following Victory in Patent Litigation Appeal
|
|
Jun 08, 99
|
| 12:51 ET |
Mallinckrodt Acquires Exclusive Worldwide Rights To Expandable Intrauterine Sensor Technology
|
|
May 17, 99
|
| 10:30 ET |
Mallinckrodt Provides Outlook For Fiscal 2000
|
|
May 04, 99
|
| 16:52 ET |
Mallinckrodt Introduces New CloudNine(TM) Auto-CPAP System To Treat Obstructive Sleep Apnea
|
|
Apr 23, 99
|
| 15:15 ET |
Mallinckrodt Board of Directors Declares Quarterly Dividend
|
|
Apr 20, 99
|
| 18:58 ET |
Mallinckrodt Comments on CalPERS' Decision
|
|
| 07:31 ET |
Mallinckrodt Reports Record Third-Quarter Earnings Per Share From Continuing Operations, Increasing 39 Percent Over FY98
|
|
Mar 18, 99
|
| 18:37 ET |
Mallinckrodt Records More Than 200 Product Clearances Worldwide During 1998
|
|
Mar 09, 99
|
| 09:30 ET |
OPTISON(R), the First and Only Commercially Available Ultrasound Imaging Agent Is a Subset of More Than Twelve Presentations at the American College of Cardiology
|
|
Feb 17, 99
|
| 17:27 ET |
Mallinckrodt to Redeem Rights Plan; Declares Quarterly Dividend
|
|
Feb 08, 99
|
| 17:34 ET |
Mallinckrodt Acquires Life Design Systems, Strengthens Position In Respiratory Product Line
|
|
Jan 27, 99
|
| 07:00 ET |
Mallinckrodt Reports Second-Quarter Earnings from Continuing Operations of 49 Cents Per Share; SEC Review is Completed
|
|
Jan 14, 99
|
| 12:46 ET |
Mallinckrodt Receives FDA Approval to Market Three Dosage Strengths Of Methylphenidate Hydrochloride
|
|
Dec 23, 98
|
| 11:04 ET |
Mallinckrodt Begins Clinical Trials of New Device To Combat Tissue Buildup Following Angioplasty
|
|
Dec 09, 98
|
| 13:10 ET |
Abstracts to be Presented at EuroEcho 2 Will Focus on Ultrasound Imaging Agent, Optison
|
|
Dec 01, 98
|
| 15:12 ET |
Mallinckrodt Sells Medical Gas Distribution Systems to Beacon Medical Products
|
|
Nov 18, 98
|
| 11:31 ET |
Mallinckrodt Respiratory Group Introduces GoodKnight 418 for Home Care Treatment of Obstructive Sleep Apnea
|
|
Nov 05, 98
|
| 13:46 ET |
Mallinckrodt's Nellcor Puritan Bennett Product Lines Receive Zenith Award From American Association For Respiratory Care
|
|
Oct 21, 98
|
| 14:07 ET |
Mallinckrodt Determined to Reward Shareholders While Expanding its Businesses, Chairman Says at Annual Meeting
|
|
Oct 20, 98
|
| 07:02 ET |
Mallinckrodt Reports First-Quarter Earnings From Continuing Operations Of 44 Cents Per Share , up 19 Percent Over Prior Year
|
|
Sep 02, 98
|
| 16:22 ET |
Mallinckrodt Board Adopts Changes to Shareholder Rights Plan
|
|
Aug 17, 98
|
| 17:16 ET |
KnightStar 335 Cleared for Treating Patients with Respiratory Failure In Hospital, Institutional Settings
|
|
| 16:39 ET |
KnightStar 335 Cleared for Treating Patients with Respiratory Failure In Hospital, Institutional Settings
|
|
Aug 13, 98
|
| 07:00 ET |
Mallinckrodt Reports Fiscal Year 1998 Earnings
|
|
Aug 12, 98
|
| 13:41 ET |
Mallinckrodt Board of Directors Declares Quarterly Dividend
|
|
Aug 07, 98
|
| 12:11 ET |
Mallinckrodt Announces Trade Secret Litigation Settlement Reached
|
|
Jul 01, 98
|
| 14:57 ET |
Mallinckrodt to Close Nellcor Puritan Bennett Facilities in Lenexa, Kansas
|
|
Jun 24, 98
|
| 16:36 ET |
Mallinckrodt Comments on Expectations for Current Fiscal Year, Outlook for Fiscal 1999
|
|
Jun 18, 98
|
| 13:54 ET |
Mallinckrodt Names New President of Respiratory Group
|
|
Jun 11, 98
|
| 10:36 ET |
Mallinckrodt Announces New Simplicity Spirometer Approved for Marketing by FDA
|
|
Jun 03, 98
|
| 14:04 ET |
Mallinckrodt Inc. Announces New Nellcor Puritan Bennett Ventnet(TM) Remote Monitoring System Can Assist 24 Ventilated Patients Simultaneously
|
|
Jun 01, 98
|
| 12:34 ET |
Mallinckrodt Becomes America's First Medical Device Manufacturer To Receive ISO 14001 Certification
|
|
May 27, 98
|
| 08:00 ET |
Mallinckrodt and Molecular Biosystems Launch OPTISON in Europe
|
|
May 19, 98
|
| 08:00 ET |
Molecular Biosystems and Mallinckrodt Report Final European Approval of OPTISON(TM)
|
|
May 12, 98
|
| 12:40 ET |
GastroMARK MRI Contrast Agent Now Part of Mallinckrodt Agreement With Premier
|
|
May 06, 98
|
| 17:14 ET |
FDA Clears 840 Ventilator for Marketing in the United States
|
|
| 17:14 ET |
FDA Clears 840 Ventilator for Marketing in the United States
|
|
Apr 27, 98
|
| 10:44 ET |
Mallinckrodt Sponsoring Worldwide Radiopharmaceutical Collaboration With Top Academic Researchers
|
|
Apr 21, 98
|
| 17:51 ET |
Mallinckrodt Provides Near-Term Outlook In Conjunction with Third Quarter Earnings Report
|
|
| 07:03 ET |
Mallinckrodt Reports Third Quarter Earnings from Continuing Operations of 62 Cents Per Share, Excluding Acquisition- and Divestiture-Related Items
|
|
Apr 16, 98
|
| 11:03 ET |
Mallinckrodt Board Of Directors Declares Quarterly Dividend
|
|
Apr 10, 98
|
| 10:28 ET |
Mallinckrodt Names Investor Relations Vice President
|
|
Mar 23, 98
|
| 11:19 ET |
Mallinckrodt, Molecular Biosystems Report Early Market Success With Optison(TM)
|
|
Mar 20, 98
|
| 11:25 ET |
Guidant and Mallinckrodt Enter New Agreement For Distribution of Peripheral Products
|
|
Mar 10, 98
|
| 12:13 ET |
Mallinckrodt Sponsors Three Papers On Treatment Of Restenosis
|
|
Mar 09, 98
|
| 12:40 ET |
New Drug Application for OPTIMARK MRI Contrast Agent Accepted For Review by FDA, Announces Mallinckrodt Inc.
|
|
Feb 23, 98
|
| 11:31 ET |
Mallinckrodt Product Clearances Total Nearly 40 Worldwide During 1997
|
|
Feb 19, 98
|
| 16:10 ET |
Mallinckrodt Board of Directors Declares Quarterly Dividend
|
|
Feb 10, 98
|
| 11:19 ET |
Mallinckrodt Inc. Purchases Trigate (Pty) Ltd., South African Medical Products Distributor
|
|
Jan 29, 98
|
| 09:30 ET |
OPTISON(TM) Recommended For European Approval; New Ultrasound Imaging Agent Will Aid in Detection of Cardiac Disease
|
|
Jan 28, 98
|
| 10:11 ET |
OPTISON(TM) Off to a Solid Start in Ultrasound Imaging Market
|
|
Jan 27, 98
|
| 08:31 ET |
Mallinckrodt Reports Second Quarter Earnings From Continuing Operations Of 33 Cents Per Share, Excluding Acquisition- and Divestiture-Related Items
|
|
Jan 22, 98
|
| 08:31 ET |
Mallinckrodt Exploring Additional Portfolio Realignments
|
|
Jan 05, 98
|
| 08:15 ET |
New Ultrasound Imaging Agent, OPTISON(TM), Cleared By FDA; First of the New Generation Ultrasound Agents
|
|
Dec 18, 97
|
| 08:31 ET |
Mallinckrodt and Japan-Based Daiichi Radioisotope Laboratories Ltd. Enter Radiopharmaceutical Distribution Agreement
|
|
Dec 16, 97
|
| 13:01 ET |
Mallinckrodt Inc. Files Shelf Registration
|
|
| 09:27 ET |
Larkin Plans to Step Down as Head of Nellcor Puritan Bennett
|
|
| 09:26 ET |
Larkin Plans to Step Down as Head of Nellcor Puritan Bennett
|
|
| 08:30 ET |
Lark Plans to Step Down as Head of Nellcor Puritan Bennett
|
|
Dec 15, 97
|
| 16:44 ET |
Mallinckrodt Baker Enters Joint Venture With Samsung America to Build $30 Million Ultrapure Microelectronic Chemicals Plant in Temple, Texas
|
|
Nov 25, 97
|
| 10:26 ET |
Mallinckrodt Wins Stay of Injunction in WarmTouch(R) Blanket Case
|
|
Nov 19, 97
|
| 15:56 ET |
Baerlocher USA Buys Mallinckrodt's Hydense(TM) Metallic Stearate Business
|
|
Nov 05, 97
|
| 12:57 ET |
Mallinckrodt Announces Officer-Level Appointments
|
|
Oct 23, 97
|
| 07:50 ET |
Mallinckrodt Reports First-Quarter Earnings From Continuing Operations Of 39 Cents Per Share, Excluding Acquisition-Related Items
|
|
Oct 17, 97
|
| 10:39 ET |
Mallinckrodt Sells Additive Preblend Business to Ciba Specialty Chemicals
|
|
Oct 15, 97
|
| 15:59 ET |
Mallinckrodt Board Declares Quarterly Dividend; Three Directors Elected at Company's Annual Meeting
|
|
Oct 02, 97
|
| 16:13 ET |
Mallinckrodt Can Continue to Sell WarmTouch(R) Blankets in U. S.; Appeals Court Stays Injunction;
|
|
Sep 23, 97
|
| 17:47 ET |
Mallinckrodt Updates Investors on Nellcor Acquisition, First-Quarter Prospects
|
|
Aug 25, 97
|
| 17:56 ET |
Mallinckrodt Board of Directors Declares Quarterly Dividend
|
|
Jul 29, 97
|
| 10:51 ET |
Mallinckrodt Commences Tender Offer For Nellcor Puritan Bennett
|
|
Jul 14, 97
|
| 14:11 ET |
Mallinckrodt Completes Expansion of Pharmaceutical Products Manufacturing Facility in St. Louis
|
|
Jun 27, 97
|
| 10:19 ET |
Mallinckrodt to Expand Hobart Facility
|
|
Jun 26, 97
|
| 10:18 ET |
Mallinckrodt Secures FDA Clearance To Supply U.S. Customers With Molybdenum From Netherlands Facility
|
|
Jun 10, 97
|
| 10:08 ET |
Mallinckrodt Signs 5-Year Agreement with Indian Company, Cadila Pharmaceuticals Ltd.
|
|
May 07, 97
|
| 09:03 ET |
Brand Name Chosen for Proposed Ultrasound Imaging Agent FS069
|
|
May 05, 97
|
| 09:03 ET |
Mallinckrodt, Medi-Physics Reach Agreement on Myoview(TM) Heart Imaging Agent
|
|
Apr 23, 97
|
| 10:47 ET |
Mallinckrodt Supporting Molecular Biosystems in FS069 Case
|
|
Apr 21, 97
|
| 13:03 ET |
Mallinckrodt's Board Of Directors Declare Quarterly Dividend
|
|
Apr 14, 97
|
| 08:33 ET |
GastroMARK(R) Now Available in The U. S. for Magnetic Resonance Imaging Of Gastrointestinal Tract
|
|
Apr 01, 97
|
| 10:11 ET |
Mallinckrodt Announces Divestiture of Tastemaker Operations
|
|
Mar 06, 97
|
| 12:59 ET |
Mallinckrodt, Molecular Biosystems File For Marketing Clearance of Ultrasound Imaging Agent, FS069, In European Union
|
|
Feb 25, 97
|
| 14:09 ET |
FDA Advisory Panel Recommends Clearance of ALBUNEX(R) Ultrasound Imaging Agent for Use in Diagnosing Fallopian Tube Patency
|
|
| 13:40 ET |
Mallinckrodt's Board of Directors Declare Quarterly Dividend
|
|
Feb 12, 97
|
| 14:00 ET |
Mallinckrodt to Supply Radiopharmaceuticals to Premier, Inc.'s, 1,800 Hospital and Healthcare Organizations
|
|
Feb 05, 97
|
| 08:59 ET |
Mallinckrodt Announces Roche Will Acquire Tastemaker Operations; Reiterates Focus on Core Businesses, Share Repurchases
|
|
| 08:25 ET |
Roche to Acquire Tastemaker Operations From Hercules, Mallinckrodt
|
|
Jan 21, 97
|
| 09:27 ET |
Mallinckrodt Reports 16 Percent Increase in Second Quarter Earnings per Share From Continuing Operations
|
|
Dec 16, 96
|
| 08:31 ET |
Molecular Biosystems, Mallinckrodt Expand Partnership for Marketing of FS069
|
|
Dec 13, 96
|
| 12:54 ET |
Mallinckrodt Adopts Executive Stock Ownership Guidelines
|
|
Nov 20, 96
|
| 12:32 ET |
Mallinckrodt Acquires D. M. Graham Laboratories, Inc.
|
|
Oct 23, 96
|
| 13:43 ET |
Investigator Reports Use of Ultrasound Contrast Imaging Agent, FS069, Is Associated With Significant Cost Savings as a Result of Enhanced Diagnostic Yield
|
|
| 09:11 ET |
Mallinckrodt Reports 1st Quarter Earnings From Continuing Operations of 48 Cents Per Share
|
|
Oct 18, 96
|
| 09:40 ET |
Molecular Biosystems, Mallinckrodt File For PMA for Next Generation Ultrasound Imaging Agent, FS069
|
|
Oct 16, 96
|
| 13:22 ET |
Mallinckrodt Board Increases Quarterly Dividend; Four Directors Elected at Company's Annual Meeting
|
|
Oct 04, 96
|
| 16:08 ET |
Colorectal Cancer Detection Agent Cleared for Sale in Europe
|
|
Sep 30, 96
|
| 15:18 ET |
Mallinckrodt, METASYN Form Strategic Alliance
|
|
